搜索临床试验以:Moderate hepatic impaired
总计12503个结果
-
Novartis Pharmaceuticals完全的
-
MedDay Pharmaceuticals SAEurofins Optimed终止
-
OSI Pharmaceuticals完全的
-
Novo Nordisk A/S完全的
-
Janssen Research & Development, LLC撤销
-
GlaxoSmithKline完全的
-
Neurocrine Biosciences完全的Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects美国
-
Tibotec Pharmaceuticals, Ireland完全的
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Novartis Pharmaceuticals招聘中
-
Aristotle University Of Thessaloniki424 General Military Hospital招聘中
-
Bristol-Myers Squibb招聘中
-
Gilead Sciences招聘中
-
Johannes Gutenberg University MainzInterdisciplinary Center Clinical Trials (IZKS), University Medical Center Mainz招聘中